
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
National Cancer Institute, Bethesda, Maryland 20892-7058 [N. H., M. J. R., M. R. E-B., A. M. G., S. M. D., P. R. T.]; Shanxi Cancer Hospital and Institute, Taiyuan, Shanxi, China 030013 [Z-Z. T., Q-H. W., X-Y. H., T. D.]; National Human Genome Research Institute, Bethesda, Maryland 20892 [M. P.]; and Information Management Service, Inc., Silver Spring, Maryland 20904 [C. G.]
Chromosomal regions with frequent allelic loss may point to major susceptibility genes that will assist in understanding molecular events involved in esophageal carcinogenesis. Esophageal squamous cell carcinoma samples and blood from 46 patients, including 23 patients with and 23 patients without a family history of upper gastrointestinal cancer, were screened using laser microdissected DNA and tested for loss of heterozygosity (LOH) at 18 marker loci representing 14 chromosomal regions (on 2q, 3p, 4p, 4p, 5q, 6q, 8p, 9p, 9q, 11p, 13q, 14q, 15q, and 17p) identified in an earlier genome-wide scan to have frequent LOH. Clinical/pathological and lifestyle risk factor data were also collected. For all 46 tumors combined, the lowest frequency LOH for any of the 18 markers was 37%, and 8 markers showed LOH in
75% of informative tumors. One marker (D13S894 on 13q) showed greater LOH in patients with a positive family history (93% versus 50%; P = 0.04), whereas two markers (D6S1027 on 6q and D9S910 on 9q) had significantly more LOH in patients with metastasis, and one marker (D4S2361 on 4p) showed significantly higher LOH in patients with a lower pathological tumor grade. No relation was seen between LOH and lifestyle risk factors. This study confirms the previously observed high frequency LOH for these 14 chromosomal regions, including a locus on 13q where LOH is more common in patients with a family history of upper gastrointestinal cancer than in those without such history, suggesting that a gene in this area may be involved in genetic susceptibility to esophageal cancer.
This article has been cited by other articles:
![]() |
R. Natrajan, J. Louhelainen, S. Williams, J. Laye, and M. A. Knowles High-Resolution Deletion Mapping of 15q13.2-q21.1 in Transitional Cell Carcinoma of the Bladder Cancer Res., November 15, 2003; 63(22): 7657 - 7662. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hu, A. M. Goldstein, P. S. Albert, C. Giffen, Z.-Z. Tang, T. Ding, P. R. Taylor, and M. R. Emmert-Buck Evidence for a Familial Esophageal Cancer Susceptibility Gene on Chromosome 13 Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1112 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Su, N. Hu, J. Shih, Y. Hu, Q.-H. Wang, E. Y. Chuang, M. J. Roth, C. Wang, A. M. Goldstein, T. Ding, et al. Gene Expression Analysis of Esophageal Squamous Cell Carcinoma Reveals Consistent Molecular Profiles Related to a Family History of Upper Gastrointestinal Cancer Cancer Res., July 15, 2003; 63(14): 3872 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hu, G. Li, W.-J. Li, C. Wang, A. M. Goldstein, Z.-Z. Tang, M. J. Roth, S. M. Dawsey, J. Huang, Q.-H. Wang, et al. Infrequent Mutation in the BRCA2 Gene in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., April 1, 2002; 8(4): 1121 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Roth, N. Hu, M. R. Emmert-Buck, Q.-H. Wang, S. M. Dawsey, G. Li, W.-J. Guo, Y.-Z. Zhang, and P. R. Taylor Genetic Progression and Heterogeneity Associated with the Development of Esophageal Squamous Cell Carcinoma Cancer Res., May 1, 2001; 61(10): 4098 - 4104. [Abstract] [Full Text] |
||||
![]() |
N. Hu, J. Huang, M. R. Emmert-Buck, Z.-Z. Tang, M. J. Roth, C. Wang, S. M. Dawsey, G. Li, W.-J. Li, Q.-H. Wang, et al. Frequent Inactivation of the TP53 Gene in Esophageal Squamous Cell Carcinoma from a High-Risk Population in China Clin. Cancer Res., April 1, 2001; 7(4): 883 - 891. [Abstract] [Full Text] |
||||
![]() |
J. Huang, N. Hu, A. M. Goldstein, M. R. Emmert-Buck, Z.-Z. Tang, M. J. Roth, Q.-H. Wang, S. M. Dawsey, X.-Y. Han, T. Ding, et al. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China Carcinogenesis, November 1, 2000; 21(11): 2019 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kainu, S.-H. H. Juo, R. Desper, A. A. Schaffer, E. Gillanders, E. Rozenblum, D. Freas-Lutz, D. Weaver, D. Stephan, J. Bailey-Wilson, et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus PNAS, August 15, 2000; 97(17): 9603 - 9608. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |